Literature DB >> 8425726

Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections.

D Weinstein1, A Wang, R Chambers, C A Stewart, H A Motz.   

Abstract

To assess the role of magnetic resonance imaging (MRI) in diagnosing osteomyelitis in diabetic foot infections, 47 diabetic patients with clinical suspicion of osteomyelitis, nonhealing foot ulcer, or soft tissue infection of the foot were examined prospectively by MRI and plain radiographs. Pathological confirmation of diagnosis was obtained in 62 bones from 32 patients. In addition, 14 patients with pathological confirmation of diagnosis underwent technetium-99 MDP triple-phase bone and gallium-67 citrate scans. MRI was significantly more sensitive and accurate (P < .01), with equal specificity in comparison to plain radiographs and technetium and gallium scans. MRI also provided a more detailed and accurate depiction of the anatomy. At early clinical follow-up, complete resection of abnormal bone on an MRI scan correlated with clinical healing. In summary, MRI is indicated when plain radiographs are negative for osteomyelitis or when the extent and accurate depiction of the infective process will facilitate surgical planning.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425726     DOI: 10.1177/107110079301400104

Source DB:  PubMed          Journal:  Foot Ankle        ISSN: 0198-0211


  3 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

2.  Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis.

Authors:  Marie T Dinh; Cybele L Abad; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

Review 3.  Imaging the diabetic foot.

Authors:  R H Gold; D J Tong; J R Crim; L L Seeger
Journal:  Skeletal Radiol       Date:  1995-11       Impact factor: 2.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.